z-logo
open-access-imgOpen Access
Bone Marrow‐Derived Mesenchymal Stem Cells Up‐Regulate Acetylcholine Receptor Delta Subunit through NRG/ErbB3‐Mediated Mitogen‐Activated Protein Kinase Pathway
Author(s) -
Chen Li,
Jiang Junjian,
Xu Jianguang,
Gu Yudong,
Xu Lei
Publication year - 2012
Publication title -
clinical and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 44
eISSN - 1752-8062
pISSN - 1752-8054
DOI - 10.1111/j.1752-8062.2011.00380.x
Subject(s) - mapk/erk pathway , mek inhibitor , microbiology and biotechnology , mesenchymal stem cell , western blot , protein kinase a , chemistry , cancer research , kinase , erbb3 , biology , receptor tyrosine kinase , biochemistry , gene
  To investigate the effect of bone marrow‐derived mesenchymal stem cells (BMSCs) on the expression of acetylcholine receptor delta subunit (AChRd), the murine skeletal muscle cell line Sol8 were grown in DMEM with 20% fetal bovine serum added with (conditional medium group) or without (control group) conditional medium of BMSC cells for 48 hours. RT‐PCR and Western blot were performed to access the mRNA and protein levels of AChRd in Sol8 cells, respectively. Western blot was used to detect total and phosphorylated protein levels of Ras, Raf‐1, Mek1/2, and Erk1/2, respectively. NRG‐1 antibody added in conditional medium of BMSCs, si‐ErbB3, and four Ras/Raf/MEK/ERK pathway inhibitors (FTS, Sulindac, U0126, and PD98059) were using to investigate the effect of AChRd levels. Our studies indicated that expression of AChRd was significantly enhanced in the conditional medium group when compared with those in control group and phosphorylation of Ras, Raf, Erk1/2 in Sol8 cells was also increased. Although gene silencing for ErbB3 gene, adding of NRG‐1 antibody in conditional medium of BMSCs or treatment of Ras/Raf/MEK/ERK pathway inhibitors can down‐regulate expression of AChRd and phosphorylation, which suggesting that the Ras/Raf/MEK/ERK pathway may be involved in BMSCs‐induced expression of AChRd. Clin Trans Sci 2012; Volume #: 1–5

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here